Company intelligence / Profile preview

CellCoTec

London, England, United Kingdomnl.linkedin.com ↗

Ownership: Private
Employees: ~24
Development stage: Other

Overview

CellCoTec developed a cell-based therapy platform for single-surgery cartilage repair targeting young patients with articular cartilage defects. The approach aimed to address an unmet need between conservative management and total joint replacement. Proof-of-concept was being established using animal models; there is no public evidence of successful late-stage clinical results or commercialization.

Therapeutic areas: Rheumatology
Modalities: Cell therapy
Industry: Biotech

Beyond the preview

Go deeper on CellCoTec.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CellCoTec.

Explore the full profile